Effectiveness and safety of moxibustion for alleviating symptoms of overactive bladder A prospective, randomized controlled, crossover-design, pilot study
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q2Scopus Q1
- 저널
- MEDICINE97(34) · 2018
- 피인용
- Web of Science 7Scopus 7
- FWCI (Scopus)
- 0.23
- JCR IF
- JCR 2017 2.028
- ISSN
- 0025-7974
저자
- 이혜윤제1저자Pusan National University Korean Medicine Hospital, Republic of Korea
- 윤영주Pusan National University Korean Medicine Hospital, Republic of Korea
- 최준용Pusan National University Korean Medicine Hospital, Republic of Korea
- 홍진우Pusan National University Korean Medicine Hospital, Republic of Korea
- 이인Pusan National University Korean Medicine Hospital, Republic of Korea
- 박성하Pusan National University Korean Medicine Hospital, Republic of Korea
- 권정남교신저자Pusan National University Korean Medicine Hospital, Republic of Korea
초록
Background: This study aimed to evaluate trial feasibility and explore the potential efficacy and safety of moxibustion in the treatment of overactive bladder (OAB). Method: A randomized, controlled, cross-over, assessor blinded design was used. This study was conducted in an outpatient department of a university hospital in Republic of Korea. The overall study period was 8 weeks. Participants were randomly allotted to either Group A or Group B. Group A participants underwent 8 to 12 sessions of moxibustion with behavioral training during the first 4 weeks, while the Group B participants received behavioral training only. Over the next 4 weeks, the treatment offered to the 2 groups was reversed (Group A participants received behavioral training only, while Group B participants underwent the moxibustion session with behavioral training). The OAB-validated 8-question awareness tool (OAB-V8), OAB symptom scores (OABSS), visual analog scale (VAS) for lower urinary tract symptoms, and frequency voiding chart were used to assess outcomes. For analysis, we used effect size, measured as Hedge's g, to present descriptive results indicating the actual difference between the groups. Results: Compared to that in Group B, the Hedge's g of OAB-V8 for the former 4 weeks in Group A was -0.248, that of OABSS was -1.531, and that of VAS was -0.713. During the latter 4 weeks, Group B showed similar effect with g=0.465, 1.207, and 0.427 for OAB-V8, OABSS, and VAS, respectively, compared to Group A. The portion of nocturnal voiding volume decreased (g=-0965), the mean voiding volume increased (g=0.690), and the voiding frequency decreased (g=-0.498) with moxibustion. Conclusions: Moxibustion might be considered as an alternative for OAB. A full-sized randomized controlled trial may be feasible with minimal modification in outcome measures and comparator population. Other information: This clinical trial has been registered on clinicaltrials. gov (NCT02271607).
키워드
CV4lower urinary tract symptomsLR3moxibustionoveractive bladderSP6QUALITY-OF-LIFESTANDARDIZATION SUB-COMMITTEEC-FOS EXPRESSIONCONTROLLED-TRIALCONTINENCE SOCIETYACUPUNCTUREVALIDATIONADULTSELECTROACUPUNCTUREINCONTINENCE
식별자
- Scopus EID
- 2-s2.0-85052678099
- WoS UID
- 000446592300098



로그인
연구물 목록으로